Literature DB >> 25197351

Sarcomatoid variant of ALK- anaplastic large cell lymphoma involving multiple lymph nodes and both lungs with production of proinflammatory cytokines: report of a case and review of literature.

Lu Yu1, Lin Li Yan1, Shou Jing Yang1.   

Abstract

Sarcomatoid variant of anaplastic large cell lymphoma (ALCL) is one of the rarest histologic variants of ALCL that consists of large, bizarre, often spindle-shaped, neoplastic cells resembling a soft tissue sarcoma. We report here such a case of ALCL with both pulmonary and multiple nodal involvement in a 47-year-old woman who initially presented with fever, cough, sputum, itching skin, and weight loss. The initial transbronchial lung biopsy showed discohesive pleomorphic malignant cells in a strong inflammatory milieu reminiscent of inflammatory malignant fibrous histiocytoma (MFH). Subsequent cervical lymph node biopsy revealed a spindle cell sarcoma predominantly composed of plump spindle and oval neoplastic cells in interweaving fascicles, with sparse inflammatory infiltrates, resembling pleomorphic-storiform type of MFH. However, these tumor cells in the lung and node lesions revealed essentially similar immunohistochemical features that were positive for CD30, EMA, TIA-1, granzyme B, and fascin, but negative for anaplastic lymphoma kinase (ALK), and T- or B-lineage-specific marker. The spindled cells stains diffuse strong positive for smooth muscle actin (SMA), along with vimentin. Further studies showed that the tumor produced large quantities of the proinflammatory cytokines interleukin-2 (IL-2), IL-6, and IL-8, which we believe may contribute to the pathogenesis of sarcomatoid transformation of this tumor, and was associated with the patient's inflammatory symptoms. To the best of our knowledge, this is the first reported case of sarcomatoid variant of ALK-negative ALCL with null cell phenotype and in situ production of proinflammatory cytokines presenting as multiple nodes and pulmonary involvement.

Entities:  

Keywords:  ALK; CD30; anaplastic large-cell lymphoma; anaplastic lymphoma kinase; cytokines; inflammation; lung; lymph node; sarcomatoid variant

Mesh:

Substances:

Year:  2014        PMID: 25197351      PMCID: PMC4152041     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  32 in total

1.  Sarcomatoid variant of anaplastic large cell lymphoma with cytoplasmic ALK and alpha-smooth muscle actin expression: a mimic of inflammatory myofibroblastic tumor.

Authors:  R Suzuki; M Seto; S Nakamura; A Nakagawa; K Hara; K Takeuchi
Journal:  Am J Pathol       Date:  2001-07       Impact factor: 4.307

Review 2.  CD30(+) anaplastic large cell lymphoma: a review of its histopathologic, genetic, and clinical features.

Authors:  H Stein; H D Foss; H Dürkop; T Marafioti; G Delsol; K Pulford; S Pileri; B Falini
Journal:  Blood       Date:  2000-12-01       Impact factor: 22.113

3.  Ki-1 (CD30)-positive anaplastic large cell lymphoma, sarcomatoid variant accompanied by spontaneously regressing lymphadenopathy.

Authors:  K Kashiwabara; H Nakamura; H Kusama; K Kishi; H Yagyu; S Takagi; T Matsuoka
Journal:  Intern Med       Date:  1999-01       Impact factor: 1.271

4.  The World Health Organization classification of neoplastic diseases of the haematopoietic and lymphoid tissues: Report of the Clinical Advisory Committee Meeting, Airlie House, Virginia, November 1997.

Authors:  N L Harris; E S Jaffe; J Diebold; G Flandrin; H K Muller-Hermelink; J Vardiman; T A Lister; C D Bloomfield
Journal:  Histopathology       Date:  2000-01       Impact factor: 5.087

5.  Sarcomatoid variant of anaplastic large cell lymphoma mimicking a primary breast cancer: a challenging diagnosis.

Authors:  Emílio M Pereira; Sueli A Maeda; Jorge S Reis-Filho
Journal:  Arch Pathol Lab Med       Date:  2002-06       Impact factor: 5.534

6.  Histological and immunohistochemical characterization of extranodal diffuse large-cell lymphomas with prominent spindle cell features.

Authors:  J Wang; N C Sun; Y Nozawa; D A Arber; P Chu; K L Chang; L M Weiss
Journal:  Histopathology       Date:  2001-11       Impact factor: 5.087

7.  Sarcomatoid variant of anaplastic large-cell Ki-1 lymphoma.

Authors:  J K Chan; R Buchanan; C D Fletcher
Journal:  Am J Surg Pathol       Date:  1990-10       Impact factor: 6.394

8.  Primary anaplastic large cell lymphoma of the lung: a clinicopathologic study of five patients.

Authors:  W L Rush; J A Andriko; J K Taubenberger; A M Nelson; S L Abbondanzo; W D Travis; M N Koss
Journal:  Mod Pathol       Date:  2000-12       Impact factor: 7.842

Review 9.  Anaplastic large cell lymphoma, ALK-negative.

Authors:  Andrés J M Ferreri; Silvia Govi; Stefano A Pileri; Kerry J Savage
Journal:  Crit Rev Oncol Hematol       Date:  2012-07-11       Impact factor: 6.312

10.  ALK- anaplastic large-cell lymphoma is clinically and immunophenotypically different from both ALK+ ALCL and peripheral T-cell lymphoma, not otherwise specified: report from the International Peripheral T-Cell Lymphoma Project.

Authors:  Kerry J Savage; Nancy Lee Harris; Julie M Vose; Fred Ullrich; Elaine S Jaffe; Joseph M Connors; Lisa Rimsza; Stefano A Pileri; Mukesh Chhanabhai; Randy D Gascoyne; James O Armitage; Dennis D Weisenburger
Journal:  Blood       Date:  2008-04-02       Impact factor: 22.113

View more
  4 in total

1.  Spindle Variant Primary Diffuse Large B Cell Lymphoma of the Colon: Case Report and Literature Review.

Authors:  Serhat Toprak; Zehra Bozdag; Nese Karadag; Sami Akbulut
Journal:  J Gastrointest Cancer       Date:  2022-01-11

2.  Synchronous primary lung sarcomatous carcinoma and lung squamous cell carcinoma: a case report.

Authors:  Maoyuan Zhao; Qiuyang Jing; Zhouguang Hui
Journal:  Int J Clin Exp Pathol       Date:  2020-03-01

Review 3.  Clinical Analysis of 50 Cases of Primary Pulmonary Lymphoma: A Retrospective Study and Literature Review.

Authors:  Mingbin Hu; Weiguo Gu; Shaoqing Chen; Jinhong Mei; Weijia Wang
Journal:  Technol Cancer Res Treat       Date:  2022 Jan-Dec

Review 4.  Anaplastic lymphoma kinase-special immunity and immunotherapy.

Authors:  Ye Guo; Hanfei Guo; Yongfei Zhang; Jiuwei Cui
Journal:  Front Immunol       Date:  2022-07-25       Impact factor: 8.786

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.